Dry Eye and Autoimmune Disease
Sjogren's Disease and Dry Eye
Up to 4 million Americans have Sjogren's disease, and the eyes are affected in nearly every case. Yet most people go undiagnosed for years, and they often see an eye doctor first. Here is how Sjogren's drives dry eye, how it is diagnosed, and how it is treated.
Key takeaways
- Sjogren's is a chronic autoimmune disease that attacks the moisture-producing glands, and dry eye is the most common sign, present in about 94% of patients.
- The eye doctor is often the first to spot it. Roughly 1 in 10 people with significant aqueous-deficient dry eye has undiagnosed Sjogren's.
- There is no single test. Diagnosis combines in-office eye tests, blood biomarkers such as the Sjo panel, and a rheumatology review using the ACR-EULAR criteria.
- Up to 40% of patients are seronegative, so normal blood work does not rule it out.
- There is no cure, but Sjogren's-related dry eye is very treatable, and treating it aggressively protects the cornea and your vision.
Quick answer. If your dry eye is severe, has not responded to standard drops, or comes with dry mouth, fatigue, or joint pain, ask to be screened for Sjogren's. Start with a comprehensive dry eye exam that includes objective testing, then your eye doctor can order blood biomarkers and coordinate a rheumatology referral if needed.
What is Sjogren's disease?
Sjogren's disease, formerly called Sjogren's syndrome, is a chronic autoimmune disease in which the immune system mistakenly attacks the body's own moisture-producing glands, primarily the lacrimal glands that make tears and the salivary glands that make saliva. The result is dryness that is more profound and more damaging than ordinary dry eye.
Sjogren's is not rare. It is thought to be the second most common autoimmune rheumatic disease after rheumatoid arthritis, affecting an estimated 4 million Americans, roughly 1 in every 85 people.
Americans estimated to have Sjogren's disease
Sjogren's Foundation, 2024
Average time from first symptoms to diagnosis
RMD Open, 2026
Female-to-male ratio of those affected
Autoimmune Registry
Of Sjogren's patients experience dry eye disease
Sjogren's Foundation, 2024
The eye doctor is often the first to find it. Approximately 1 in 10 patients with clinically significant aqueous-deficient dry eye has undiagnosed underlying Sjogren's, yet most of those cases are never flagged. Cornea, 2019
Primary and secondary Sjogren's
Primary Sjogren's
Occurs on its own, without another underlying autoimmune condition. This is the most common presentation, with an estimated 1.07 million Americans affected. Dry eye and dry mouth are usually the leading features.
Secondary Sjogren's
Develops alongside another autoimmune disease, most often rheumatoid arthritis, lupus, or primary biliary cirrhosis. An estimated 710,000 Americans are affected. Dry eye appears in the context of the other condition.
Prevalence estimates: DelveInsight US, 2024.
How Sjogren's attacks the eyes
In Sjogren's, white blood cells called lymphocytes infiltrate and damage the lacrimal glands that produce the watery, aqueous layer of the tear film. As that layer fails, the surface of the eye is left exposed.
- Lymphocytes infiltrate the lacrimal gland tissue, reducing its ability to produce the aqueous tear layer, so tear volume drops below the level needed to keep the surface healthy.
- With less aqueous volume, the tear film breaks down faster and tear osmolarity rises, exposing the cornea to friction and stress between blinks.
- Chronic surface stress releases MMP-9 and other inflammatory mediators, and the goblet cells that make the mucin layer begin to fail, setting up a self-reinforcing cycle of inflammation and dryness.
Untreated, Sjogren's-associated dry eye can produce corneal staining, erosions, filamentary keratitis, scarring, ulcers, and vision loss. It is typically more severe than non-autoimmune dry eye, which is why the right diagnosis and proactive treatment matter so much.
How severe is it? In the SJOGRENSER registry of 437 patients across multiple rheumatology centers, 86.5% presented with severe or very severe dry eye. Rheumatology International, 2018
Signs and symptoms
Sjogren's is a whole-body disease, and its symptoms often overlap with aging and other common complaints, which is a major reason it goes unrecognized for years.
Eye symptoms
Present in about 94% of patients, and often the first and most prominent complaint.
- Persistent dry, gritty, or sandy feeling
- Burning or stinging, often worse by the end of the day
- Blurred vision that clears briefly with blinking
- Light sensitivity
- Heavy, fatigued eyelids
- Stringy mucus on waking
- Redness and irritation that drops do not resolve
- Discomfort with contact lenses
- Watery eyes despite dryness, from reflex tearing
Mouth and throat symptoms
- Persistent dry mouth, even with enough water
- Difficulty swallowing dry foods
- Needing to sip water while eating or talking
- Accelerated dental decay despite good hygiene
- Swollen or painful salivary glands
- Dry or cracked lips, hoarse voice
Systemic symptoms
- Fatigue, often profound
- Joint pain and swelling
- Brain fog and concentration difficulty
- Dry skin or other dryness
- Raynaud's phenomenon
- Numbness or tingling in hands or feet
- Muscle pain
Serious complication risk. Non-Hodgkin lymphoma risk is significantly increased in Sjogren's, with long-term studies estimating a 3 to 4% risk over 10 years, well above the general population. This is one reason a real diagnosis matters.
Who is at risk?
Sjogren's is also underdiagnosed in men and younger patients, and up to 40% of confirmed patients are seronegative. Consider screening if any of these apply:
- Women, who are about 9 times more likely than men to develop it
- Dry eye that fails to respond to standard treatment
- Dry eye and dry mouth together
- Moderate-to-severe aqueous-deficient dry eye with low Schirmer scores
- Dry eye plus unexplained fatigue or joint pain
- Dry eye plus Raynaud's, numbness, or recurrent dental decay
- Severe dry eye in a woman under 50 with no obvious cause
- A personal or family history of autoimmune disease
How to get tested
There is no single test that diagnoses Sjogren's. Diagnosis combines objective tests, some in the eye doctor's office and others through blood work or rheumatology.
Step 1. In-office eye tests
Your eye doctor is often the first to raise the possibility, and these can be done in a single dry eye exam:
- Schirmer's test, measuring aqueous tear production; 5 mm or less of wetting in 5 minutes is one of the ACR-EULAR criteria
- Tear osmolarity (ScoutPro), where elevated readings and inter-eye asymmetry point to a failing tear film
- Ocular surface staining with fluorescein and lissamine green; a staining score of 5 or higher is a criterion
- MMP-9 testing (InflammaDry) to confirm active surface inflammation
- Tear film stability testing such as non-invasive breakup time
Step 2. Blood biomarker testing
- Sjo Advanced Diagnostic Panel, which screens 7 biomarkers for early detection
- Standard SS-A (anti-Ro) and SS-B (anti-La) antibodies; positive SS-A is weighted heavily in the criteria
- ANA and rheumatoid factor as supporting autoimmune markers
Step 3. Rheumatology referral
If findings suggest Sjogren's, or if blood work is negative but suspicion stays high, a rheumatology referral is the next step. Your eye doctor should share Schirmer's, staining, osmolarity, and biomarker results to support it. The rheumatologist may add a minor salivary gland biopsy, a salivary flow measurement, and the full ACR-EULAR score; a total of 4 or more confirms the diagnosis.
Start here. The fastest path to finding out if Sjogren's is driving your dry eye is a comprehensive dry eye exam with a doctor who performs objective testing.
Treatment for Sjogren's-related dry eye
There is no cure for Sjogren's, but the dry eye it causes is very treatable, and treating it aggressively protects the surface of the eye. Care is matched to severity and is often shared between your eye doctor and rheumatologist.
Lubrication and surface support
- Preservative-free artificial tears, used frequently; preservatives like BAK are harsh on an already damaged surface
- Nighttime gels or ointments for overnight exposure
- Autologous serum eye drops, blood-derived drops rich in growth factors
- Moisture chamber eyewear or scleral lenses that hold a fluid reservoir over the cornea
Anti-inflammatory therapy
- Cyclosporine eye drops (Restasis, Vevye), first-line for the lacrimal gland inflammation
- Lifitegrast (Xiidra), which blocks lymphocyte adhesion and migration
- Short-term topical steroids for acute flares
- Systemic hydroxychloroquine, managed by rheumatology
Tear conservation and procedures
- Punctal plugs to slow tear drainage and keep tears and medication on the eye longer
- Ocular surface irrigation (Rinsada) to reduce inflammatory load
- Low-level light therapy with documented improvement in staining and Schirmer scores
- IPL (OptiLight) when an evaporative component coexists
- Amniotic membrane (Prokera) for severe surface damage
Find a dry eye doctor near you who understands Sjogren's
Not every dry eye practice screens for Sjogren's. Our doctor locator shows practices equipped for the objective testing, osmolarity, MMP-9, Schirmer's, and staining, that the diagnosis depends on.
Learn more about Sjogren's and dry eye
Signs and symptoms guide
The full list of ocular and systemic symptoms, and how to describe them so your doctor raises the Sjogren's flag.
Getting tested
Every test in the workup, from the eye exam to the Sjo panel to biopsy and the rheumatology criteria.
Treatment guide
A deep dive on every option, from preservative-free drops and cyclosporine to scleral lenses, serum drops, and procedures.
Frequently asked questions
Can my eye doctor diagnose Sjogren's?
An eye doctor can perform several of the objective tests that are part of the diagnostic criteria, including Schirmer's, ocular staining, and advanced blood biomarker testing such as the Sjo panel. They can identify the dry eye pattern that raises suspicion and start the workup, then coordinate a rheumatology referral for the formal diagnosis.
My blood tests came back negative. Can I still have Sjogren's?
Yes, and this is important. Up to 40% of confirmed patients are seronegative, meaning their SS-A and SS-B antibody tests come back normal even with active disease. A negative antibody panel does not rule out Sjogren's, which is why eye findings, symptoms, and sometimes a lip biopsy all matter.
Is Sjogren's dry eye treated differently than regular dry eye?
Yes. Sjogren's-associated dry eye is typically more severe and is driven mainly by aqueous tear deficiency, low tear volume, rather than the evaporative, meibomian-gland pattern of common dry eye. It usually needs more aggressive lubrication, anti-inflammatory therapy, and tear conservation, often coordinated with a rheumatologist.
How serious is Sjogren's?
It is a serious systemic disease. Beyond the eye and mouth, Sjogren's raises the risk of non-Hodgkin lymphoma well above the general population, and it can affect the joints, lungs, kidneys, and nerves. Early diagnosis and consistent care matter.
Why does it take so long to get a Sjogren's diagnosis?
A few reasons: the early symptoms, fatigue, dry eyes, joint pain, are common and easy to attribute to aging or stress; up to 40% of patients are seronegative so routine blood work looks normal; and the workup spans eye care, blood testing, and rheumatology, so no single visit confirms it.
What is the Sjo panel?
The Sjo Advanced Diagnostic Panel is a blood test that screens seven biomarkers for early Sjogren's detection, including the traditional SS-A and SS-B antibodies plus newer early markers. Many eye doctors can order it in-office, which is why the eye exam is often where the path to diagnosis begins.
Can Sjogren's dry eye cause vision loss?
Untreated, it can. Severe aqueous deficiency can lead to corneal staining, erosions, filamentary keratitis, scarring, and ulcers. In one large study, 13% of Sjogren's patients developed vision-threatening ocular findings, which is why aggressive, proactive treatment is the standard.
I have a diagnosis. How do I find a dry eye doctor who understands Sjogren's?
Look for practices that offer objective dry eye testing, osmolarity, MMP-9, Schirmer's, and staining, and that coordinate care with rheumatology. Our doctor locator identifies practices equipped for exactly this kind of testing and management.
Clinical sources and references
- Sjogren's Foundation. Living with Sjogren's and Dry Eye, 2024.
- Bunya VY, et al. Sjogren's Syndrome: More Than Just Dry Eye. Cornea, 2019.
- Shiboski CH, et al. 2016 ACR-EULAR Classification Criteria for Primary Sjogren's Syndrome. Arthritis and Rheumatology, 2016.
- Ramos-Casals M, et al. Factors associated with severe dry eye in primary Sjogren's syndrome. Rheumatology International, 2018.
- Shen L, et al. Novel Autoantibodies in Sjogren's Syndrome. Clinical Ophthalmology, 2015.
- Tukaj S, et al. Management of Sjogren's Dry Eye Disease. Pharmaceutics, 2022.
- Ng A, et al. Low-Level Light Therapy for Dry Eye, Randomized Controlled Trial. Nature Scientific Reports, 2022.
This page is for educational purposes and does not constitute medical advice. If you think you may have Sjogren's disease, please see a qualified eye care professional or rheumatologist for evaluation.
Get answers about your dry eye
Find a practice equipped to screen for Sjogren's, or shop preservative-free relief while you get evaluated.
